<DOC>
	<DOC>NCT01590693</DOC>
	<brief_summary>The purpose of this study is to determine whether botulinum toxin A (BTX) adds a favourable effect to treatment of idiopathic toe-walking with below knee walking casts. The specific hypothesis to be tested is that a combination of BTX and casting is more effective than casting treatment alone in reducing toe-walking in 5-15 year old children. Evaluation methods include 3-D gait analysis, parents' perception of toe-walking frequency, passive joint range of motion measurements, and strength of ankle dorsal extension.</brief_summary>
	<brief_title>Botulinum Toxin A for Idiopathic Toe-walking</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Children with idiopathic toewalking 515 years of age Previous treatment for idiopathic toewalking, such as, Achilles tendon surgery, casting, orthotics, and BTX treatment. Flexion contracture beyond 10 degrees in the ankle</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Gait</keyword>
</DOC>